BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37331963)

  • 1. Effects of sevoflurane on lung epithelial permeability in experimental models of acute respiratory distress syndrome.
    Zhai R; Lenga Ma Bonda W; Leclaire C; Saint-Béat C; Theilliere C; Belville C; Coupet R; Blondonnet R; Bouvier D; Blanchon L; Sapin V; Jabaudon M
    J Transl Med; 2023 Jun; 21(1):397. PubMed ID: 37331963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAGE inhibition reduces acute lung injury in mice.
    Blondonnet R; Audard J; Belville C; Clairefond G; Lutz J; Bouvier D; Roszyk L; Gross C; Lavergne M; Fournet M; Blanchon L; Vachias C; Damon-Soubeyrand C; Sapin V; Constantin JM; Jabaudon M
    Sci Rep; 2017 Aug; 7(1):7208. PubMed ID: 28775380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Receptor for Advanced Glycation End Products in Regulating Lung Fluid Balance in Lipopolysaccharide-induced Acute Lung Injury and Infection-Related Acute Respiratory Distress Syndrome.
    Wang H; Wang T; Yuan Z; Cao Y; Zhou Y; He J; Shen Y; Zeng N; Dai L; Wen F; Chen L
    Shock; 2018 Oct; 50(4):472-482. PubMed ID: 29040215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The receptor for advanced glycation end products mediates dysfunction of airway epithelial barrier in a lipopolysaccharides-induced murine acute lung injury model.
    Li J; Wang K; Huang B; Li R; Wang X; Zhang H; Tang H; Chen X
    Int Immunopharmacol; 2021 Apr; 93():107419. PubMed ID: 33548580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for Advanced Glycation End-Products Promotes Activation of Alveolar Macrophages through the NLRP3 Inflammasome/TXNIP Axis in Acute Lung Injury.
    Lenga Ma Bonda W; Fournet M; Zhai R; Lutz J; Blondonnet R; Bourgne C; Leclaire C; Saint-Béat C; Theilliere C; Belville C; Bouvier D; Blanchon L; Berger M; Sapin V; Jabaudon M
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sevoflurane on lung alveolar epithelial wound healing and survival in a sterile in vitro model of acute respiratory distress syndrome.
    Loubet F; Robert C; Leclaire C; Theillière C; Saint-Béat C; Lenga Ma Bonda W; Zhai R; Minet-Quinard R; Belville C; Blanchon L; Sapin V; Garnier M; Jabaudon M
    Exp Cell Res; 2024 May; 438(1):114030. PubMed ID: 38583855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the Receptor for Advanced Glycation End-Products in Acute Respiratory Distress Syndrome: A Randomised Laboratory Trial in Piglets.
    Audard J; Godet T; Blondonnet R; Joffredo JB; Paquette B; Belville C; Lavergne M; Gross C; Pasteur J; Bouvier D; Blanchon L; Sapin V; Pereira B; Constantin JM; Jabaudon M
    Sci Rep; 2019 Jun; 9(1):9227. PubMed ID: 31239497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alveolar epithelial glycocalyx shedding aggravates the epithelial barrier and disrupts epithelial tight junctions in acute respiratory distress syndrome.
    Li J; Qi Z; Li D; Huang X; Qi B; Feng J; Qu J; Wang X
    Biomed Pharmacother; 2021 Jan; 133():111026. PubMed ID: 33378942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of dexmedetomidine in cecal ligation perforation-induced acute lung injury through HMGB1/RAGE pathway regulation and pyroptosis activation.
    Sun H; Hu H; Xu X; Fang M; Tao T; Liang Z
    Bioengineered; 2021 Dec; 12(2):10608-10623. PubMed ID: 34747306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAGE inhibition alleviates lipopolysaccharides-induced lung injury via directly suppressing autophagic apoptosis of type II alveolar epithelial cells.
    Xiong X; Dou J; Shi J; Ren Y; Wang C; Zhang Y; Cui Y
    Respir Res; 2023 Jan; 24(1):24. PubMed ID: 36691012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the Alveolar Epithelium: Plasma Soluble Receptor for Advanced Glycation End Products Is Associated With Oxygenation Impairment, Mortality, and Extrapulmonary Organ Failure in Children With Acute Respiratory Distress Syndrome.
    Lim MJ; Zinter MS; Chen L; Wong KMY; Bhalla A; Gala K; Guglielmo M; Alkhouli M; Huard LL; Hanudel MR; Vangala S; Schwingshackl A; Matthay M; Sapru A
    Crit Care Med; 2022 May; 50(5):837-847. PubMed ID: 34678846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study.
    Ferrando C; Aguilar G; Piqueras L; Soro M; Moreno J; Belda FJ
    Eur J Anaesthesiol; 2013 Aug; 30(8):455-63. PubMed ID: 23545542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sevoflurane for Sedation in Acute Respiratory Distress Syndrome. A Randomized Controlled Pilot Study.
    Jabaudon M; Boucher P; Imhoff E; Chabanne R; Faure JS; Roszyk L; Thibault S; Blondonnet R; Clairefond G; Guérin R; Perbet S; Cayot S; Godet T; Pereira B; Sapin V; Bazin JE; Futier E; Constantin JM
    Am J Respir Crit Care Med; 2017 Mar; 195(6):792-800. PubMed ID: 27611637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor for advanced glycation end products expressed on alveolar epithelial cells is the main target for hyperoxia-induced lung injury.
    Ota C; Ishizawa K; Yamada M; Tando Y; He M; Takahashi T; Yamaya M; Yamamoto Y; Yamamoto H; Kure S; Kubo H
    Respir Investig; 2016 Mar; 54(2):98-108. PubMed ID: 26879479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor for advanced glycation end-products enhances lung epithelial wound repair: An in vitro study.
    Zhai R; Blondonnet R; Ebrahimi E; Belville C; Audard J; Gross C; Choltus H; Henrioux F; Constantin JM; Pereira B; Blanchon L; Sapin V; Jabaudon M
    Exp Cell Res; 2020 Jun; 391(2):112030. PubMed ID: 32330509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin αDβ2 (CD11d/CD18) mediates experimental malaria-associated acute respiratory distress syndrome (MA-ARDS).
    de Azevedo-Quintanilha IG; Vieira-de-Abreu A; Ferreira AC; Nascimento DO; Siqueira AM; Campbell RA; Teixeira Ferreira TP; Gutierrez TM; Ribeiro GM; E Silva PM; Carvalho AR; Bozza PT; Zimmerman GA; Castro-Faria-Neto HC
    Malar J; 2016 Jul; 15(1):393. PubMed ID: 27473068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome.
    Guo WA; Knight PR; Raghavendran K
    Intensive Care Med; 2012 Oct; 38(10):1588-98. PubMed ID: 22777515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.
    Smit PJ; Guo WA; Davidson BA; Mullan BA; Helinski JD; Knight PR
    J Surg Res; 2014 Sep; 191(1):214-23. PubMed ID: 24814199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling.
    Lapar DJ; Hajzus VA; Zhao Y; Lau CL; French BA; Kron IL; Sharma AK; Laubach VE
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):299-305. PubMed ID: 21980055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lumican is elevated in the lung in human and experimental acute respiratory distress syndrome and promotes early fibrotic responses to lung injury.
    Wang K; Wang Y; Cao Y; Wang H; Zhou Y; Gao L; Zeng Z; Cheng M; Jin X; Chen J; Wen F; Wang T
    J Transl Med; 2022 Sep; 20(1):392. PubMed ID: 36059026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.